RET-IN-13

RET-IN-13, a quinoline-based compound, effectively inhibits the RET kinase, demonstrating IC50 values of 0.5 nM for RET (WT) and 0.9 nM for RET (V804M) . It holds promise for research into tumors and intestinal diseases associated with abnormal RET activation.